| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000034006 |
| Receipt No. | R000038773 |
| Scientific Title | Psychosomatic study on subjective assessment of physical activity in chronic pain patients |
| Date of disclosure of the study information | 2018/09/04 |
| Last modified on | 2021/08/15 (Ver. 2) |
| Basic information | ||
| Public title | Psychosomatic study on subjective assessment of physical activity in chronic pain patients | |
| Acronym | Psychosomatic study on subjective assessment of physical activity in chronic pain patients | |
| Scientific Title | Psychosomatic study on subjective assessment of physical activity in chronic pain patients | |
| Scientific Title:Acronym | Psychosomatic study on subjective assessment of physical activity in chronic pain patients | |
| Region |
|
|
| Condition | ||||
| Condition | chronic pain | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | We clarified the degree of difference between physical activity by objective measuring instruments and physical activity by subjective scale and the relationship between psychological characteristics and introceptive awareness in chronic pain patients, We will consider the support of effective physical activity for future chronic pain patients. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | physical activity
Accelerometer(ActiGraph GT3X-BT ActiGraph LLC, Pensacola, FL, USA) Questionnaire(The International Physical Activity Questionnaire Short Form) |
| Key secondary outcomes | psychological assessment
heartbeat tracking task |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | 1 Basic information of research subject: Gender, age, disease, illness period, BMI, education history, preference, medication situation, surgical history, marital status
2 Cognitive function test: MMSE (Mini Mental State Examination) 3 Heartbeat tracking task 4 Objective physical activity measurement: Accelerometer(ActiGraph GT3X-BT ActiGraph LLC, Pensacola, FL, USA) 5 Psychological assessment :Short-Form McGill Pain Questionnaire(SF-MPQ), Pain Self Efficacy Questionnaire(PSEQ), Hospital Anxiety and Depression Scale(HADS), Pain Catastrophizing Scale(PCS), Toront Alexithymia Scale 20(TAS-20), Chronic Pain Acceptance Questionnaire(CPAQ), The Somatosensory Amplification Scale(SSAS), SF-8, Sense of Coherence scale(SOC) 6 Subjective Physical Activity Scale:The International Physical Activity Questionnaire Short Form(IPAQ-SF) |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1 Persons whose age is 20 years or older at the time of acquiring consent
2 After receiving sufficient explanation for participation in this research, those who gained consent from the research subjects' free will with sufficient understanding |
|||
| Key exclusion criteria | 1 Persons who has a decline in cognitive function
2 Persons with arrhythmia 3 Those whose mental illness is the main disease name 4 Persons who lack ability to express intention 5 Other,those who have judged that the research director is inappropriate as the research subject |
|||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kansai Medical University Graduate School | ||||||
| Division name | department of psychosomatic medicine | ||||||
| Zip code | |||||||
| Address | 2-5-1 Shin-machi, Hirakata City, Osaka 573-0101 Japan | ||||||
| TEL | 072-804-0101 | ||||||
| shizumah@hirakata.kmu.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kansai Medical University Graduate School | ||||||
| Division name | department of psychosomatic medicine | ||||||
| Zip code | |||||||
| Address | 2-5-1 Shin-machi, Hirakata City, Osaka 573-0101 Japan | ||||||
| TEL | 072-804-0101 | ||||||
| Homepage URL | |||||||
| shizumah@hirakata.kmu.ac.jp | |||||||
| Sponsor | |
| Institute | Department of psychosomatic medicine, Kansai Medical University Graduate School |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of psychosomatic medicine, Kansai Medical University Graduate School |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Hankai Hospital
Kyoto College of Medical Health |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000038773 |